Published in Chemioterapia on February 01, 1988
Coccoid Helicobacter pylori not culturable in vitro reverts in mice. Microbiol Immunol (1994) 1.79
Neosartorya fischeri var fischeri (Wehmer) Malloch and Cain 1972 (anamorph: Aspergillus fischerianus Samson and Gams 1985) as a cause of mycotic keratitis. Eur J Epidemiol (1990) 1.69
Cross-resistance between methicillin and cephalosporins for staphylococci: a general assumption not true for cefamandole. Antimicrob Agents Chemother (1984) 1.61
Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group. Clin Infect Dis (1999) 1.54
Multicenter comparative evaluation of six commercial systems and the national committee for clinical laboratory standards m27-a broth microdilution method for fluconazole susceptibility testing of Candida species. J Clin Microbiol (2002) 1.51
Helicobacter pylori: a fickle germ. Microbiol Immunol (1994) 1.47
An experimental model for the acute and chronic evaluation of intra-aneurysmal pressure. J Endovasc Surg (1997) 1.45
Enterococcus flavescens sp. nov., a new species of enterococci of clinical origin. Int J Syst Bacteriol (1992) 1.36
SmaI macrorestriction analysis of Italian isolates of erythromycin-resistant Streptococcus pyogenes and correlations with macrolide-resistance phenotypes. Microb Drug Resist (2001) 1.35
Identification, clinical distribution, and susceptibility to methicillin and 18 additional antibiotics of clinical Staphylococcus isolates: nationwide investigation in Italy. J Clin Microbiol (1984) 1.21
Commercial identification systems often fail to identify Providencia stuartii. J Clin Microbiol (1988) 1.14
Pharmacokinetics of fluconazole in normal volunteers. Chemotherapy (1993) 1.10
Brain atrophy and lesion load in a large population of patients with multiple sclerosis. Neurology (2005) 1.10
New plate medium for screening and presumptive identification of gram-negative urinary tract pathogens. J Clin Microbiol (1988) 1.06
Helicobacter pylori isolated from stomach corpus and antrum: comparison of DNA patterns. J Infect (1996) 1.06
Pharmacokinetics of sulbactam/ampicillin in humans after intravenous and intramuscular injection. Chemotherapy (1990) 0.99
Phospholipase activity in Malassezia furfur pathogenic strains. Mycoses (1996) 0.97
In vitro antibacterial activity of rifaximin against Clostridium difficile, Campylobacter jejunii and Yersinia spp. Drugs Exp Clin Res (1987) 0.95
Piliated Bacteroides fragilis strains adhere to epithelial cells and are more sensitive to phagocytosis by human neutrophils than nonpiliated strains. Infect Immun (1984) 0.95
Laboratory studies with BL-S 578 (Cefadroxil) a new broad-spectrum orally active cephalosporin. Chemotherapy (1979) 0.93
Pharmacokinetics of ceforanide. Antimicrob Agents Chemother (1982) 0.93
The effect of oxygen on the growth and cell morphology of Helicobacter pylori. FEMS Microbiol Lett (1998) 0.93
Synthesis and antifungal activity of pyrido[3',2':4,5]thieno[3,2-d]- 1,2,3-triazine derivatives. Farmaco (1993) 0.92
Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome. J Perinatol (2010) 0.91
Recovery of Helicobacter pylori ATCC43504 from a viable but not culturable state: regrowth or resuscitation? APMIS (1998) 0.91
Antibacterial activity and anti-biofilm effect of chitosan against strains of Streptococcus mutans isolated in dental plaque. Int J Immunopathol Pharmacol (2009) 0.91
Multicentric study of seroprevalence of Borrelia burgdorferi and Anaplasma phagocytophila in high-risk groups in regions of central and southern Italy. Int J Immunopathol Pharmacol (2004) 0.89
In vitro activity of ciprofloxacin against aerobic bacteria isolated in a southern European hospital. Antimicrob Agents Chemother (1987) 0.89
Distribution of mef(A)-containing genetic elements in erythromycin-resistant isolates of Streptococcus pyogenes from Italy. Clin Microbiol Infect (2005) 0.88
Pharmacokinetics of cefadroxil after oral administration in humans. Antimicrob Agents Chemother (1982) 0.87
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients. Infection (2013) 0.86
o-Nitrophenyl-beta-D-galactopyranoside-urease-indole broth, a new composite tube medium for Salmonella screening. J Clin Microbiol (1986) 0.86
Enhanced clearing of Helicobacter pylori after omeprazole plus roxithromycin treatment. FEMS Microbiol Lett (1991) 0.85
Incidence of hemagglutination activity among pathogenic and non-pathogenic Bacteroides fragilis strains and role of capsule and pili in HA and adherence. FEMS Microbiol Lett (1989) 0.84
New plate medium for growth and detection of urease activity of Helicobacter pylori. J Clin Microbiol (1992) 0.84
Pharmacokinetics of teicoplanin. Chemotherapy (1988) 0.83
Why do idiopathic scoliosis patients participate more in gymnastics? Scand J Med Sci Sports (2006) 0.83
Plasmid curing effect of trovafloxacin. FEMS Microbiol Lett (2000) 0.83
Twelve aberrant strains of Staphylococcus aureus subsp. aureus from clinical specimens. J Clin Microbiol (1993) 0.83
Bacteriolytic effect of teicoplanin. J Gen Microbiol (1991) 0.83
In vitro extracellular and intracellular activity of two newer and two earlier fluoroquinolones against Listeria monocytogenes. Eur J Clin Microbiol Infect Dis (1997) 0.83
Analysis of different genetic traits and their association with biofilm formation in Staphylococcus epidermidis isolates from central venous catheter infections. Eur J Clin Microbiol Infect Dis (2006) 0.82
Topical kanamycin: an effective therapeutic option in aerobic vaginitis. J Chemother (2006) 0.81
[Production of coagulase and thermonuclease in 366 strains of staphylococci belonging to different lyogroups]. Boll Ist Sieroter Milan (1985) 0.81
Purpuromycin: an antibiotic inhibiting tRNA aminoacylation. RNA (1997) 0.81
Antibacterial activity of various antibiotics against oral streptococci isolated in the oral cavity. Int J Immunopathol Pharmacol (2012) 0.81
Contamination of preservation fluid in kidney transplantation: single-center analysis. Transplant Proc (2010) 0.81
Microbiological/clinical characteristics and validation of topical therapy with kanamycin in aerobic vaginitis: a pilot study. Int J Antimicrob Agents (2004) 0.80
Survey of clinical isolates of Staphylococcus aureus for borderline susceptibility to antistaphylococcal penicillins. Eur J Clin Microbiol Infect Dis (1993) 0.80
T-mod pathway, a reduced sequence for identification of gram-negative urinary tract pathogens. J Clin Microbiol (1989) 0.80
New model systems provide insights into Myc-induced transformation. Oncogene (2011) 0.80
Detection of fungal DNA in lysis-centrifugation blood culture for the diagnosis of invasive candidiasis in neonatal patients. Clin Microbiol Infect (2011) 0.80
[Otomycosis: etiology and analysis of predisposing factors]. Boll Ist Sieroter Milan (1984) 0.79
A linear model for the pharmacokinetics of azithromycin in healthy volunteers. Chemotherapy (1997) 0.79
In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones. Chemotherapy (1998) 0.79
Efficacy and safety of cerivastatin 0.8 mg in patients with hypercholesterolaemia: the pivotal placebo-controlled clinical trial. Cerivastatin Study Group. J Int Med Res (2000) 0.79
In vitro activity of fluconazole, voriconazole and caspofungin against clinical yeast isolates. J Chemother (2007) 0.78
Microbiological evidence of Helicobacter pylori from dental plaque in dyspeptic patients. New Microbiol (1995) 0.78
The relapse rate of multiple sclerosis changes during pregnancy: a cohort study. Acta Neurol Scand (2004) 0.78
Assessment of the left atrial appendage mechanical function by three-dimensional echocardiography. Eur J Echocardiogr (2002) 0.78
Antistaphylococcal and antistreptococcal killing kinetics of ciprofloxacin, ofloxacin, sparfloxacin, and trovafloxacin. Eur J Clin Microbiol Infect Dis (1998) 0.77
Incidence of lower respiratory tract infections caused by Mycoplasma, Chlamydia and Legionella: an Italian Multicenter Survey. J Chemother (1994) 0.77
Occurrence of Candida species colonization in a population of denture-wearing immigrants. Int J Immunopathol Pharmacol (2013) 0.77
Antibiotic susceptibility of respiratory pathogens recently isolated in Italy: focus on cefditoren. J Chemother (2010) 0.77
Econazole-polycarbophil, a new delivery system for topical therapy: microbiological and clinical results on vaginal candidiasis. J Chemother (2008) 0.77
Long-term efficacy and safety of cerivastatin 0.8 mg in patients with primary hypercholesterolemia. Clin Cardiol (2001) 0.76
Quantitative assessment of mechanical prosthetic valve area by 3-dimensional transesophageal echocardiography. J Am Soc Echocardiogr (2001) 0.76
In vitro activity of cefditoren versus other antibiotics against S. pneumoniae clinical strains isolated in Italy. Int J Immunopathol Pharmacol (2010) 0.76
Evidence for an oral-faecal transmission of Helicobacter pylori infection in an experimental murine model. APMIS (1999) 0.76
In vitro selection of resistance to clarithromycin in Streptococcus pneumoniae clinical isolates. J Chemother (2005) 0.76
Purification and characterisation of two GST's forms from Rhizobium leguminosarum with a high affinity to herbicides. Int J Immunopathol Pharmacol (2003) 0.76
Double sugar-tyrosine medium improves O-1 phage Salmonella screening. J Clin Microbiol (1992) 0.75
Failure to detect Helicobacter pylori in nasal mucus in H pylori positive dyspeptic patients. J Clin Pathol (1995) 0.75
[Study on the antibacterial activity of the combination cefazolin-dicloxacillin]. Nuovi Ann Ig Microbiol (1977) 0.75
[Experimental studies of amoxycillin-flucloxacillin combination]. Antibiotica (1974) 0.75
In vitro antibacterial activity of rifaximin against Campylobacter pylori (Campylobacter pyloridis). J Chemother (1989) 0.75
2,2'-Bipyridyl-6-carboxamidoximes with potential antitumor and antimicrobial properties. Farmaco Sci (1986) 0.75
[Experimental studies on the antibacterial activity of the association cephaloridine-dicloxacilline (author's transl)]. Ann Sclavo (1977) 0.75
Pharmacokinetics of cefatrizine after oral administration in human volunteers. Int J Clin Pharmacol Res (1985) 0.75
Pharmacokinetics of cefoperazone after single and multiple doses. Int J Clin Pharmacol Res (1986) 0.75
[Determining levels of bacteria present in urine by means of a gauged loop (author's transl)]. Quad Sclavo Diagn (1979) 0.75
[Lividomycin: microbiological activity in vitro and in vivo]. Ann Sclavo (1974) 0.75
[Efficacy of the carbenicillin-cephaloridine association]. Ann Sclavo (1976) 0.75
Serum levels and urinary excretion in humans of BL-S 578 (cefadroxil), a new semisynthetic cephalosporin. Chemotherapy (1980) 0.75
Serum lysozyme increased by fructose-1, 6-diphosphate in men, rabbits, and mice. J Leukoc Biol (1984) 0.75
[Antibacterial activity of a carbenicillin-cephaloridin combination]. Ann Sclavo (1976) 0.75
Determination of cefatrizine levels in blood, tonsils, paranasal sinuses and middle ear. Drugs Exp Clin Res (1985) 0.75
Human intravenous and intramuscular pharmacokinetics of amoxicillin. Int J Clin Pharmacol Res (1984) 0.75